{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T18:01:26Z","timestamp":1791396086833,"version":"4.3.3"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,17]],"date-time":"2013-07-17T00:00:00Z","timestamp":1374019200000},"content-version":"vor","delay-in-days":2116,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Cell"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.ccr.2007.08.031","type":"journal-article","created":{"date-parts":[[2007,12,6]],"date-time":"2007-12-06T16:07:16Z","timestamp":1196957236000},"page":"367-380","source":"Crossref","is-referenced-by-count":214,"title":["FLT3 Mutations Confer Enhanced Proliferation and Survival Properties to Multipotent Progenitors in a Murine Model of Chronic Myelomonocytic Leukemia"],"prefix":"10.1016","volume":"12","author":[{"given":"Benjamin H.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Tothova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross L.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalija","family":"Buza-Vidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana\u00a0E.","family":"Cullen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth P.","family":"McDowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Adelsperger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Fr\u00f6hling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J.P.","family":"Huntly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miloslav","family":"Beran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten Eirik","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Gary","family":"Gilliland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccr.2007.08.031_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35004599","article-title":"A clonogenic common myeloid progenitor that gives rise to all myeloid lineages","volume":"404","author":"Akashi","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ccr.2007.08.031_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJMoa020150","article-title":"Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta","volume":"347","author":"Apperley","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ccr.2007.08.031_bib3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1535-6108(03)00003-5","article-title":"Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification","volume":"3","author":"Armstrong","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2007.08.031_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ccr.2007.08.031_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/sj.leu.2404532","article-title":"Transgenic mice expressing Tel-FLT3, a constitutively activated form of FLT3, develop myeloproliferative disease","volume":"21","author":"Baldwin","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2007.08.031_bib6","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10428190701216386","article-title":"Prognostic factors and risk assessment in chronic myelomonocytic leukemia: Validation study of the M.D. Anderson Prognostic Scoring System","volume":"48","author":"Beran","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ccr.2007.08.031_bib7","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1158\/0008-5472.CAN-05-0422","article-title":"Constitutive activation of Akt by Flt3 internal tandem duplications is necessary for increased survival, proliferation, and myeloid transformation","volume":"65","author":"Brandts","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2007.08.031_bib8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1182\/blood.V87.3.1089.bloodjournal8731089","article-title":"Expression of the hematopoietic growth factor receptor FLT3 (STK-1\/Flk2) in human leukemias","volume":"87","author":"Carow","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib9","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1126\/science.287.5459.1804","article-title":"Hematopoietic stem cell quiescence maintained by p21cip1\/waf1","volume":"287","author":"Cheng","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ccr.2007.08.031_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2004-07-2942","article-title":"AML-associated Flt3 kinase domain mutations show signal transduction differences compared with Flt3 ITD mutations","volume":"106","author":"Choudhary","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib11","first-page":"885","article-title":"Expression of the FLT3 gene in human leukemia-lymphoma cell lines","volume":"8","author":"DaSilva","year":"1994","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2007.08.031_bib12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1182\/blood-2006-05-024828","article-title":"Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders","volume":"109","author":"David","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib13","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1535-6108(03)00051-5","article-title":"MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP","volume":"3","author":"Deguchi","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2007.08.031_bib14","first-page":"588","article-title":"Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells","volume":"10","author":"Drexler","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2007.08.031_bib15","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1200\/JCO.1988.6.9.1417","article-title":"Prognostic factors in adult chronic myelomonocytic leukemia: An analysis of 107 cases","volume":"6","author":"Fenaux","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ccr.2007.08.031_bib16","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1182\/blood-2002-05-1440","article-title":"Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: A study of the AML Study Group Ulm","volume":"100","author":"Frohling","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib17","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood.V86.5.1661.bloodjournal8651661","article-title":"Multi-level effects of flt3 ligand on human hematopoiesis: Expansion of putative stem cells and proliferation of granulomonocytic progenitors\/monocytic precursors","volume":"86","author":"Gabbianelli","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib18","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib19","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1182\/blood-2004-11-4430","article-title":"FLT3-ITD and tyrosine kinase domain mutants induce 2 distinct phenotypes in a murine bone marrow transplantation model","volume":"105","author":"Grundler","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib20","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/sj.onc.1203354","article-title":"Tandem-duplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines","volume":"19","author":"Hayakawa","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2007.08.031_bib21","first-page":"748","article-title":"Stem cell factor, but not flt3 ligand, induces differentiation and activation of human mast cells","volume":"24","author":"Hjertson","year":"1996","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.ccr.2007.08.031_bib22","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1038\/sj.leu.2400770","article-title":"Tandem duplications of the FLT3 receptor gene are associated with leukemic transformation of myelodysplasia","volume":"11","author":"Horiike","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2007.08.031_bib23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/088800199276994","article-title":"High expression but no internal tandem duplication of FLT3 in normal hematopoietic cells","volume":"16","author":"Ishii","year":"1999","journal-title":"Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ccr.2007.08.031_bib24","doi-asserted-by":"crossref","first-page":"8283","DOI":"10.1073\/pnas.122233699","article-title":"PML\/RARalpha and FLT3-ITD induce an APL-like disease in a mouse model","volume":"99","author":"Kelly","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ccr.2007.08.031_bib25","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1182\/blood.V99.1.310","article-title":"FLT3 internal tandem duplication mutations associated with human acute myeloid leukemias induce myeloproliferative disease in a murine bone marrow transplant model","volume":"99","author":"Kelly","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib26","first-page":"3074","article-title":"Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia","volume":"93","author":"Kiyoi","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib27","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/sj.leu.2401130","article-title":"Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product","volume":"12","author":"Kiyoi","year":"1998","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2007.08.031_bib28","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0092-8674(00)80453-5","article-title":"Identification of clonogenic common lymphoid progenitors in mouse bone marrow","volume":"91","author":"Kondo","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2007.08.031_bib29","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V98.6.1752","volume":"98","author":"Kottaridis","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib30","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1038\/sj.onc.1208933","article-title":"FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model","volume":"24","author":"Lee","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2007.08.031_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ccr.2005.03.023","article-title":"Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis","volume":"7","author":"Levine","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ccr.2007.08.031_bib32","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2007.06525.x","article-title":"FLT3\/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem\/progenitor cells","volume":"137","author":"Li","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ccr.2007.08.031_bib33","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1309\/JT5BE2L1FGG8P8Y6","article-title":"Activating FLT3 mutations are detectable in chronic and blast phase of chronic myeloproliferative disorders other than chronic myeloid leukemia","volume":"126","author":"Lin","year":"2006","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ccr.2007.08.031_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/1074-7613(95)90167-1","article-title":"Targeted disruption of the flk2\/flt3 gene leads to deficiencies in primitive hematopoietic progenitors","volume":"3","author":"Mackarehtschian","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.ccr.2007.08.031_bib35","first-page":"1368","article-title":"Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines","volume":"9","author":"Meierhoff","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2007.08.031_bib36","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood.V96.12.3907","article-title":"Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways","volume":"96","author":"Mizuki","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib37","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/1074-7613(94)90037-X","article-title":"The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype","volume":"1","author":"Morrison","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.ccr.2007.08.031_bib38","first-page":"1911","article-title":"Internal tandem duplication of the flt3 gene found in acute myeloid leukemia","volume":"10","author":"Nakao","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2007.08.031_bib39","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1182\/blood.V99.3.840","article-title":"Prognostic factors and scoring systems in chronic myelomonocytic leukemia: A retrospective analysis of 213 patients","volume":"99","author":"Onida","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib40","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2004-01-0168","article-title":"Activating FLT3 mutations in CD117\/KIT positive T-Cell acute lymphoblastic leukemias","volume":"104","author":"Paietta","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib41","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0145-2126(02)00303-X","article-title":"Flt-3 and c-kit mutation studies in\u00a0a spectrum of chronic myeloid disorders including systemic mast cell disease","volume":"27","author":"Pardanani","year":"2003","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ccr.2007.08.031_bib42","first-page":"2058","article-title":"The flt3\/flk-2 ligand: Receptor distribution and action on murine haemopoietic cell survival and proliferation","volume":"9","author":"Rasko","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2007.08.031_bib43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/stem.140146","article-title":"FLT3\/FLK-2 (STK-1) Ligand does not stimulate human megakaryopoiesis in vitro","volume":"14","author":"Ratajczak","year":"1996","journal-title":"Stem Cells"},{"key":"10.1016\/j.ccr.2007.08.031_bib44","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1182\/blood-2005-06-2596","article-title":"Point mutations in the juxtamembrane domain of FLT3 define a new class of activating mutations in AML","volume":"107","author":"Reindl","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00062752-200401000-00005","article-title":"Modeling the dosage effect of oncogenes in leukemogenesis","volume":"11","author":"Ren","year":"2004","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.ccr.2007.08.031_bib46","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1182\/blood-2005-11-011429","article-title":"Roles of tyrosine 589 and 591 in STAT5 activation and transformation mediated by FLT3-ITD","volume":"108","author":"Rocnik","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib47","first-page":"595","article-title":"Hematopoietic receptors of class III receptor-type tyrosine kinases","volume":"4","author":"Rosnet","year":"1993","journal-title":"Crit. Rev. Oncog."},{"key":"10.1016\/j.ccr.2007.08.031_bib48","first-page":"238","article-title":"Human FLT3\/FLK2 receptor tyrosine kinase is expressed at the surface of normal and malignant hematopoietic cells","volume":"10","author":"Rosnet","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.ccr.2007.08.031_bib49","doi-asserted-by":"crossref","first-page":"3338","DOI":"10.1038\/sj.onc.1207456","article-title":"FLT3 receptors with internal tandem duplications promote cell viability and proliferation by signaling through Foxo proteins","volume":"23","author":"Scheijen","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.ccr.2007.08.031_bib50","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V100.1.59","article-title":"Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: Correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease","volume":"100","author":"Schnittger","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib51","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.1182\/blood-2003-11-3775","article-title":"Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia","volume":"103","author":"Smith","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib52","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2141.2004.04808.x","article-title":"Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia","volume":"124","author":"Stirewalt","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ccr.2007.08.031_bib53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ccr.2007.08.031_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1182\/blood-2004-03-0891","article-title":"Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412","volume":"105","author":"Stone","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib55","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1182\/blood.V99.12.4326","article-title":"Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: Association with FAB subtypes and identification of subgroups with poor prognosis","volume":"99","author":"Thiede","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib56","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","article-title":"FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress","volume":"128","author":"Tothova","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ccr.2007.08.031_bib57","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1182\/blood-2003-11-3896","article-title":"After chronic myelogenous leukemia: Tyrosine kinase inhibitors in other hematologic malignancies","volume":"105","author":"Wadleigh","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib58","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1182\/blood-2005-12-4824","article-title":"Expression of Jak2V617F causes a polycythemia vera-like disease with associated myelofibrosis in a murine bone marrow transplant model","volume":"107","author":"Wernig","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.ccr.2007.08.031_bib59","first-page":"7233","article-title":"Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: A cancer and leukemia group B study","volume":"61","author":"Whitman","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.ccr.2007.08.031_bib60","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1182\/blood.V97.8.2434","article-title":"Activating mutation of D835 within the activation loop of FLT3 in human hematologic malignancies","volume":"97","author":"Yamamoto","year":"2001","journal-title":"Blood"}],"container-title":["Cancer Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610807002632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1535610807002632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T05:56:36Z","timestamp":1588139796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1535610807002632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S1535610807002632"],"URL":"https:\/\/doi.org\/10.1016\/j.ccr.2007.08.031","relation":{},"ISSN":["1535-6108"],"issn-type":[{"value":"1535-6108","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}